Literature DB >> 19720729

Protein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropin.

Lisa A Vuchak1, Oxana M Tsygankova, Gregory V Prendergast, Judy L Meinkoth.   

Abstract

Thyrotropin (TSH) regulates thyroid cell proliferation and function through cAMP-mediated signaling pathways that activate protein kinase A (PKA) and Epac/Rap1. The respective roles of PKA versus Epac/Rap1 in TSH signaling remain unclear. We set out to determine whether PKA and/or Rap1 mediate extracellular signal-regulated kinase (ERK) activation by TSH. Neither blocking Rap1 activity nor silencing the expression of Rap1 impaired TSH or forskolin-induced ERK activation in Wistar rat thyroid cells. Direct activation of Epac1 failed to stimulate ERK activity in starved cells, suggesting that Epac-induced Rap1 activity is not coupled to ERK activation in rat thyroid cells. By contrast, PKA activity was required for cAMP-stimulated ERK phosphorylation and was sufficient to increase ERK phosphorylation in starved cells. Expression of dominant-negative Ras inhibited ERK activation by TSH, forskolin, and N(6)-monobutyryl (6MB)-cAMP, a selective activator of PKA. Silencing the expression of B-Raf also inhibited ERK activation by TSH, forskolin, and 6MB-cAMP, but not that stimulated by insulin or serum. Depletion of B-Raf impaired TSH-induced DNA synthesis, indicating a functional role for B-Raf in TSH-regulated proliferation. Collectively, these results position PKA, Ras, and B-Raf as upstream regulators of ERK activation and identify B-Raf as a selective target of cAMP-elevating agents in thyroid cells. These data provide the first evidence for a functional role for B-Raf in TSH signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720729      PMCID: PMC2774990          DOI: 10.1124/mol.109.060129

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP.

Authors:  N Pham; I Cheglakov; C A Koch; C L de Hoog; M F Moran; D Rotin
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

2.  The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.

Authors:  Rosa Marina Melillo; Maria Domenica Castellone; Valentina Guarino; Valentina De Falco; Anna Maria Cirafici; Giuliana Salvatore; Fiorina Caiazzo; Fulvio Basolo; Riccardo Giannini; Mogens Kruhoffer; Torben Orntoft; Alfredo Fusco; Massimo Santoro
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

3.  cAMP cascade leads to Ras activation in cortical neurons.

Authors:  A Ambrosini; S Tininini; A Barassi; G Racagni; E Sturani; R Zippel
Journal:  Brain Res Mol Brain Res       Date:  2000-01-10

4.  In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.

Authors:  Nicolas Dumaz; Robert Hayward; Jan Martin; Lesley Ogilvie; Douglas Hedley; John A Curtin; Boris C Bastian; Caroline Springer; Richard Marais
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

5.  Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways.

Authors:  S Dremier; F Vandeput; F J Zwartkruis; J L Bos; J E Dumont; C Maenhaut
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

6.  Cyclic AMP activates Ras.

Authors:  O M Tsygankova; E Kupperman; W Wen; J L Meinkoth
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

7.  Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.

Authors:  Norisato Mitsutake; Jeffrey A Knauf; Shin Mitsutake; Cleo Mesa; Lei Zhang; James A Fagin
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

Review 8.  Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems.

Authors:  D L Medina; P Santisteban
Journal:  Eur J Endocrinol       Date:  2000-08       Impact factor: 6.664

Review 9.  BRAF mutation in thyroid cancer.

Authors:  M Xing
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

Review 10.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia.

Authors:  Tetsuo Kondo; Shereen Ezzat; Sylvia L Asa
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

View more
  13 in total

1.  cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.

Authors:  Hui Liao; Matthew C Hyman; Amy E Baek; Keigo Fukase; David J Pinsky
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

2.  Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.

Authors:  Xiaoyun Dong; Christopher Korch; Judy L Meinkoth
Journal:  Endocr Relat Cancer       Date:  2011-04-02       Impact factor: 5.678

3.  Rap1GAP impairs cell-matrix adhesion in the absence of effects on cell-cell adhesion.

Authors:  Lisa A Vuchak; Oxana M Tsygankova; Judy L Meinkoth
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

4.  Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation.

Authors:  Jui-Hung Yen; Virginia P Kocieda; Huie Jing; Doina Ganea
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

5.  Trace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells.

Authors:  Emily S Michael; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

6.  Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP.

Authors:  Maho Takahashi; Yanping Li; Tara J Dillon; Philip J S Stork
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

Review 7.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP.

Authors:  Yanping Li; Tara J Dillon; Maho Takahashi; Keith T Earley; Philip J S Stork
Journal:  J Biol Chem       Date:  2016-08-16       Impact factor: 5.157

9.  Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.

Authors:  Sonu Kashyap; Kyaw Zaw Hein; Claudia Cs Chini; Jorgo Lika; Gina M Warner; Laurie K Bale; Vicente E Torres; Peter C Harris; Claus Oxvig; Cheryl A Conover; Eduardo N Chini
Journal:  JCI Insight       Date:  2020-02-27

10.  Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation.

Authors:  Yanping Li; Maho Takahashi; Philip J S Stork
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.